These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31810397)

  • 1. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations.
    Weersink RA; Burger DM; Hayward KL; Taxis K; Drenth JPH; Borgsteede SD
    Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):45-57. PubMed ID: 31810397
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safe prescribing in patients with liver cirrhosis; 5 pitfalls].
    Weersink RA; Drenth JPH; Ter Borg F; Mulder MB; Taxis K; Borgsteede SD
    Ned Tijdschr Geneeskd; 2020 Oct; 164():. PubMed ID: 33201633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations of pharmacokinetics of drugs in patients with cirrhosis.
    Pena MA; Horga JF; Zapater P
    Expert Rev Clin Pharmacol; 2016; 9(3):441-58. PubMed ID: 26696448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis.
    Weersink RA; Bouma M; Burger DM; Drenth JPH; Harkes-Idzinga SF; Hunfeld NGM; Metselaar HJ; Monster-Simons MH; Taxis K; Borgsteede SD
    Drug Saf; 2018 Jun; 41(6):603-613. PubMed ID: 29330714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Licence to Prescribe.
    Kramers C; Janssen BJ; Knol W; Hessel MHM; Mulder WM; Dumont G; Maassen van den Brink A; Tichelaar J
    Br J Clin Pharmacol; 2017 Aug; 83(8):1860-1861. PubMed ID: 28256012
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic alterations in older people with dementia.
    Reeve E; Trenaman SC; Rockwood K; Hilmer SN
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):651-668. PubMed ID: 28460576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion.
    Weersink RA; Bouma M; Burger DM; Drenth JP; Hunfeld NG; Kranenborg M; Monster-Simons MH; van Putten SA; Metselaar HJ; Taxis K; Borgsteede SD
    BMJ Open; 2016 Oct; 6(10):e012991. PubMed ID: 27733414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis.
    Thomson MJ; Lok ASF; Tapper EB
    Hepatology; 2021 Jun; 73(6):2429-2440. PubMed ID: 32911564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters.
    Smit C; De Hoogd S; Brüggemann RJM; Knibbe CAJ
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):275-285. PubMed ID: 29431542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.
    Velenosi TJ; Urquhart BL
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress.
    O'Mahony D
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):15-22. PubMed ID: 31790317
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review.
    Yourman L; Concato J; Agostini JV
    Am J Geriatr Pharmacother; 2008 Jun; 6(2):119-29. PubMed ID: 18675770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interest of pharmacoepidemiology for the study of inhaled drugs.
    Molimard M; Girodet PO; Van Ganse E
    Therapie; 2019 Apr; 74(2):233-237. PubMed ID: 30392699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriateness and surveillance of medication in a cohort of diabetic patients on polypharmacy.
    Harder S; Saal K; Blauth E; Beyer M; Gerlach FM
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):104-10. PubMed ID: 19203566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of pharmacogenomics in adverse drug reactions.
    Cacabelos R; Cacabelos N; Carril JC
    Expert Rev Clin Pharmacol; 2019 May; 12(5):407-442. PubMed ID: 30916581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing comorbidities in patients with chronic heart failure: first, do no harm.
    DeJongh B; Birkeland K; Brenner M
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):171-84. PubMed ID: 25837622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in drug disposition in older adults: a focus on geriatric syndromes.
    Maher D; Ailabouni N; Mangoni AA; Wiese MD; Reeve E
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):41-52. PubMed ID: 33078628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.
    Himebauch AS; Kilbaugh TJ; Zuppa AF
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing indicators: what can Canada learn from European countries?
    Sketris IS; Fisher JE; Langille Ingram EM; Bergman U; Andersen M; Vlahović-Palčkevski V
    J Popul Ther Clin Pharmacol; 2012; 19(1):e78-98. PubMed ID: 22550125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on medication use in the neonatal intensive care unit.
    Allegaert K; Simons S; Van Den Anker J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):343-353. PubMed ID: 30741041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.